4-butyrolactone has been researched along with Adenocarcinoma of Lung in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
An, H; Bai, X; Guo, S; Kang, X; Li, S; Liu, X; Shi, S | 1 |
Blancafort, A; CufĂ, S; Haro, D; Marrero, PF; Oliveras, G; Puig, T; Relat, J | 1 |
2 other study(ies) available for 4-butyrolactone and Adenocarcinoma of Lung
Article | Year |
---|---|
Multi-target tracheloside and doxorubicin combined treatment of lung adenocarcinoma.
Topics: 4-Butyrolactone; Adenocarcinoma of Lung; Apoptosis; Cell Line, Tumor; Doxorubicin; Glucosides; Humans; Lung Neoplasms; Molecular Docking Simulation | 2022 |
Different fatty acid metabolism effects of (-)-epigallocatechin-3-gallate and C75 in adenocarcinoma lung cancer.
Topics: 4-Butyrolactone; Adenocarcinoma; Adenocarcinoma of Lung; Analysis of Variance; Animals; Apoptosis; Carnitine O-Palmitoyltransferase; Catechin; Cell Line, Tumor; Fatty Acid Synthases; Fatty Acids; Female; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Random Allocation; Signal Transduction; Weight Loss; Xenograft Model Antitumor Assays | 2012 |